Invention Publication
- Patent Title: TREATMENT OF FRAGILE X SYNDROME
-
Application No.: US18167010Application Date: 2023-02-09
-
Publication No.: US20230242599A1Publication Date: 2023-08-03
- Inventor: Raymond W. TURNER
- Applicant: UTI Limited Partnership
- Applicant Address: CA Calgary
- Assignee: UTI Limited Partnership
- Current Assignee: UTI Limited Partnership
- Current Assignee Address: CA Calgary
- Main IPC: C07K14/435
- IPC: C07K14/435 ; A61P43/00 ; A61K31/155 ; A61K31/351 ; A61K31/65 ; C07K14/005
Abstract:
The present disclosure relates generally to the treatment of Fragile X Syndrome using a recombinant fusion polypeptide comprising or consisting of a cell penetrating polypeptide, such as HIS or tat, and a Fragile X Mental Retardation protein (FMRP (298)).
Information query
